Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,421 | -17,619 | -40,833 | -16,029 | 1,481 |
| Depreciation Amortization | 4,156 | 2,072 | 7,345 | 5,557 | 3,692 |
| Accounts receivable | 111 | 7 | -261 | -898 | -214 |
| Accounts payable and accrued liabilities | -1,274 | -362 | 973 | 5,134 | 2,147 |
| Other Working Capital | -23 | -1,305 | -23,395 | -15,083 | -10,962 |
| Other Operating Activity | 4,286 | -7,897 | -48,871 | -57,599 | -51,158 |
| Operating Cash Flow | $-47,165 | $-25,104 | $-105,042 | $-78,918 | $-55,014 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -279 | -175 | -884 | -845 | -796 |
| Investing Cash Flow | $-279 | $-175 | $-884 | $-845 | $-796 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 39,783 | N/A | N/A |
| Debt Repayment | -174 | N/A | -2,754 | -2,157 | -1,414 |
| Common Stock Issued | 77,024 | 23,321 | 113,441 | 56,856 | 50,659 |
| Other Financing Activity | 0 | 0 | -88,984 | -50,385 | -340 |
| Financing Cash Flow | $76,850 | $23,321 | $61,486 | $4,314 | $48,905 |
| Beginning Cash Position | 50,850 | 50,850 | 95,290 | 95,290 | 95,290 |
| End Cash Position | 80,256 | 48,892 | 50,850 | 19,841 | 88,385 |
| Net Cash Flow | $29,406 | $-1,958 | $-44,440 | $-75,449 | $-6,905 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,165 | -25,104 | -105,042 | -78,918 | -55,014 |
| Capital Expenditure | -279 | -175 | -884 | -845 | -796 |
| Free Cash Flow | -47,444 | -25,279 | -105,926 | -79,763 | -55,810 |